Eurogin is part of the Informa Markets Division of Informa PLC


Abstract Submission

You can submit your abstract for poster display or oral presentation through our online system. Don't miss the opportunity to present your research at an internationally renowned event.

All abstracts must be submitted through the online abstract submission system.

Abstract submission deadline: October 30, 2024 

Late breaker deadline: on request – strict conditions to be complied with.

General Conditions

Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2025 Congress and has adequate financial resources to attend.

  1. Authors are requested to register for a full Conference Pass within 10 days after having received their provisional notification of acceptance.

    If the abstract presenter is registered with a group, please inform the Congress Secretariat at: [email protected] and indicate the person who booked the group registration;

  2. Abstracts must be submitted and presented in ENGLISH;

  3. Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;

  4. For proffered papers (for Free Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;

  5. Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;

  6. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;

  7. Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)

  8. All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference).
    The main author and the presenter can be the same person. They may also be identical to or different from the submitter;

  9. The main author and the presenter must be identified (by ticking the corresponding boxes);

  10. For further information and assistance please contact the scientific secretariat at [email protected]

Editing Instructions

  1. Abstracts must be submitted through the online submission system;

  2. Your abstract should not exceed a total of 3,500 characters all sections included:
    Background/ObjectivesMethodsResults, and Conclusion;

  3. The title should not be written in upper case (capitals), keep it as short as possible clearly indicating the nature of the investigation; 

  4. Please avoid complex mathematical formulae; the system allows to insert simple tables;

  5. Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned;

  6. All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract;

  7. Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;

  8. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;

  9. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;

  10. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;

  11. Drugs must be identified by their generic names and no company names should be mentioned in the title of the abstract.

Abstract Topics

For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.

1. HPV disease and COVID-19

2. Viral and molecular biology

3. Epidemiology and natural history

4. Pathogenesis

5. Immunology

6. HPV prophylactic vaccines

7. HPV therapeutic vaccines

8. Immunotherapy - Immuno-oncology - New treatments

9. HPV testing

10. HPV screening

11. Screening for women difficult to reach

12. Triage of HPV positive women

13. Self-sampling

14. Genotyping

15. Molecular markers

16. Screening methods

17. Methylation

18. Microbiome

19. Serology

20. New technologies

21. Artificial intelligence - Big data - Machine learning

22. Diagnostic procedures / management

23. Risk management

24. Colposcopy

25. Cervical neoplasia

26. Vulvar and vaginal diseases and neoplasia

27. Anal neoplasia

28. Oral HPV infection

29. HPV and oropharynx / Head and neck cancer

30. HPV and associated skin diseases

31. Genital warts

32. HPV transmission

33. Sexually transmitted diseases and HIV infection

34. Conventional therapies

35. Economics and modelling

36. Advocacy, acceptability and psychology

37. Health education

38. Low resource settings

39. Public health

40. Fertility and HPV